Stock Events

Allogene Therapeutics (ALLO) Q3 2023 Earnings

2NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.7
-0.59
-0.48
-0.37

Details

Expected EPS
-0.52
Actual EPS
-0.37
Surprise EPS
0.15
Surprise Percent
+28.85%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.37 per share for Q3 2023.

0 Comments

Share your thoughts